Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases

Marina Eskin-Schwartz; Daniel Mimouni

doi:10.1007/978-3-662-45698-9_48

Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases

Marina Eskin-Schwartz, Daniel Mimouni

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Scopus citations

Abstract

Autoimmune blistering skin disease (AIBD) is a term used to describe a heterogeneous group of cutaneous and mucosal diseases with significant morbidity and mortality. A range of ocular complications can occur in patients with AIBD, due to the underlying blistering disease or as side effects of the medications used to treat these diseases. The most common ocular presentation of AIBD is a chronic conjunctivitis, which can progress to conjunctival fibrosis and eventually chronic cicatricial conjunctivitis. Cicatrisation leads to ocular complications that include symblepharon, fornix foreshortening, entropion, trichiasis, corneal damage and neovascularisation. Clinical features in the eye overlap between the types of AIBD. Early recognition and treatment of the disease is essential to prevent irreversible scarring and progression to blindness in certain cases.

Original language	English
Title of host publication	Blistering Diseases
Subtitle of host publication	Clinical Features, Pathogenesis, Treatment
Publisher	Springer Berlin Heidelberg
Pages	483-491
Number of pages	9
ISBN (Electronic)	9783662456989
ISBN (Print)	9783662456972
DOIs	https://doi.org/10.1007/978-3-662-45698-9_48
State	Published - 1 Jan 2015
Externally published	Yes

ASJC Scopus subject areas

Medicine (all)

Access to Document

10.1007/978-3-662-45698-9_48

Cite this

@inbook{8d9323bd66be4a81b40ff1c531467269,

title = "Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases",

abstract = "Autoimmune blistering skin disease (AIBD) is a term used to describe a heterogeneous group of cutaneous and mucosal diseases with significant morbidity and mortality. A range of ocular complications can occur in patients with AIBD, due to the underlying blistering disease or as side effects of the medications used to treat these diseases. The most common ocular presentation of AIBD is a chronic conjunctivitis, which can progress to conjunctival fibrosis and eventually chronic cicatricial conjunctivitis. Cicatrisation leads to ocular complications that include symblepharon, fornix foreshortening, entropion, trichiasis, corneal damage and neovascularisation. Clinical features in the eye overlap between the types of AIBD. Early recognition and treatment of the disease is essential to prevent irreversible scarring and progression to blindness in certain cases.",

author = "Marina Eskin-Schwartz and Daniel Mimouni",

note = "Publisher Copyright: {\textcopyright} Springer-Verlag Berlin Heidelberg 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-662-45698-9_48",

language = "English",

isbn = "9783662456972",

pages = "483--491",

booktitle = "Blistering Diseases",

publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases

AU - Eskin-Schwartz, Marina

AU - Mimouni, Daniel

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Autoimmune blistering skin disease (AIBD) is a term used to describe a heterogeneous group of cutaneous and mucosal diseases with significant morbidity and mortality. A range of ocular complications can occur in patients with AIBD, due to the underlying blistering disease or as side effects of the medications used to treat these diseases. The most common ocular presentation of AIBD is a chronic conjunctivitis, which can progress to conjunctival fibrosis and eventually chronic cicatricial conjunctivitis. Cicatrisation leads to ocular complications that include symblepharon, fornix foreshortening, entropion, trichiasis, corneal damage and neovascularisation. Clinical features in the eye overlap between the types of AIBD. Early recognition and treatment of the disease is essential to prevent irreversible scarring and progression to blindness in certain cases.

AB - Autoimmune blistering skin disease (AIBD) is a term used to describe a heterogeneous group of cutaneous and mucosal diseases with significant morbidity and mortality. A range of ocular complications can occur in patients with AIBD, due to the underlying blistering disease or as side effects of the medications used to treat these diseases. The most common ocular presentation of AIBD is a chronic conjunctivitis, which can progress to conjunctival fibrosis and eventually chronic cicatricial conjunctivitis. Cicatrisation leads to ocular complications that include symblepharon, fornix foreshortening, entropion, trichiasis, corneal damage and neovascularisation. Clinical features in the eye overlap between the types of AIBD. Early recognition and treatment of the disease is essential to prevent irreversible scarring and progression to blindness in certain cases.

UR - http://www.scopus.com/inward/record.url?scp=84956714928&partnerID=8YFLogxK

U2 - 10.1007/978-3-662-45698-9_48

DO - 10.1007/978-3-662-45698-9_48

M3 - Chapter

AN - SCOPUS:84956714928

SN - 9783662456972

SP - 483

EP - 491

BT - Blistering Diseases

PB - Springer Berlin Heidelberg

ER -

Mycophenolate Mofetil for the Management of Autoimmune Bullous Diseases

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this